Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 698

    1.

    Microvascular complications in cystic fibrosis-related diabetes.

    Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A.

    Diabetes Care. 2007 May;30(5):1056-61. Epub 2007 Feb 23.PMID: 17322485 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Diabetes mellitus in patients with cystic fibrosis.

    Alves Cde A, Aguiar RA, Alves AC, Santana MA.

    J Bras Pneumol. 2007 Apr;33(2):213-21. Review. English, Portuguese. PMID: 17724542 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD).

    van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG.

    J Cyst Fibros. 2008 Nov;7(6):515-9. Epub 2008 Jul 11.PMID: 18619927 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.

    Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER.

    Diabetes Care. 2006 Dec;29(12):2660-3.PMID: 17130201 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.

    Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W.

    Diabetes Care. 2009 Sep;32(9):1626-31. Epub 2009 Jun 19.PMID: 19542209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.

    Milla CE, Billings J, Moran A.

    Diabetes Care. 2005 Sep;28(9):2141-4.PMID: 16123480 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.

    Dobson L, Stride A, Bingham C, Elworthy S, Sheldon CD, Hattersley AT.

    Pediatr Pulmonol. 2005 Feb;39(2):103-7.PMID: 15573388 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.

    Happich M, Breitscheidel L, Meisinger C, Ulbig M, Falkenstein P, Benter U, Watkins J.

    Curr Med Res Opin. 2007 Jun;23(6):1367-74. Epub 2007 May 21.PMID: 17559744 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diabetic microangiopathy in patients with cystic fibrosis.

    Sullivan MM, Denning CR.

    Pediatrics. 1989 Oct;84(4):642-7.PMID: 2780126 [PubMed - indexed for MEDLINE]Related articles

    11.

    Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.

    Sims EJ, Green MW, Mehta A.

    Diabetes Care. 2005 Jul;28(7):1581-7.PMID: 15983304 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Cystic fibrosis-related diabetes: a frequent co-morbidity]

    Della Manna T, Setian N, Rodrigues JC.

    Arq Bras Endocrinol Metabol. 2008 Mar;52(2):188-97. Review. Portuguese. PMID: 18438529 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Glucose tolerance in patients with cystic fibrosis: five year prospective study.

    Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C.

    BMJ. 1995 Sep 9;311(7006):655-9.PMID: 7549632 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.

    Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D.

    Diabetes Care. 2008 Sep;31(9):1789-94. Epub 2008 Jun 5.PMID: 18535191 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.

    Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P.

    Isr Med Assoc J. 2006 Jun;8(6):378-82.PMID: 16833164 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.

    Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB.

    Am J Clin Nutr. 2005 Feb;81(2):421-6.PMID: 15699230 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.

    Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M.

    Eur Respir J. 2005 Apr;25(4):715-7.PMID: 15802348 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Microvascular complications in South African patients with long-duration diabetes mellitus.

    Motala AA, Pirie FJ, Gouws E, Amod A, Omar MA.

    S Afr Med J. 2001 Nov;91(11):987-92.PMID: 11847923 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.

    Allen HF, Gay EC, Klingensmith GJ, Hamman RF.

    Diabetes Care. 1998 Jun;21(6):943-8.PMID: 9614612 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study.

    Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ.

    Diabetes Care. 2003 Sep;26(9):2604-8.PMID: 12941726 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data